Co-Authors
This is a "connection" page, showing publications co-authored by Chien-Te Tseng and Shinji Makino.
Connection Strength
0.908
-
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine. 2008 Feb 06; 26(6):797-808.
Score: 0.187
-
Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin. J Virol. 2015 Nov; 89(21):10970-81.
Score: 0.159
-
Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. J Virol. 2009 Jun; 83(11):5451-65.
Score: 0.102
-
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol. 2008 May; 82(9):4471-9.
Score: 0.095
-
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol. 2007 Feb; 81(3):1162-73.
Score: 0.087
-
Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. J Virol. 2006 Aug; 80(15):7287-94.
Score: 0.085
-
Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol. 2005 Jun 15; 174(12):7977-85.
Score: 0.078
-
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2021 Jun 21; 12(1):3984.
Score: 0.060
-
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2020 10 15; 11(1):5214.
Score: 0.057